How does one know when to stop aspirin therapy?

When to stop aspirin therapy depends on the original reason it was prescribed and on the balance between bleeding risk and cardiovascular protection.

How long should aspirin continue after a heart attack or stent placement?
Most guidelines recommend lifelong aspirin at 75–100 mg daily after a myocardial infarction or coronary stent unless bleeding complications or new contraindications arise.

What changes the decision to stop aspirin?
A new major bleeding event, upcoming high-bleeding-risk surgery, or a switch to an alternative antithrombotic regimen can prompt stopping. In patients who have completed dual antiplatelet therapy after stenting, aspirin is often continued alone, but the exact duration of dual therapy is individualized by cardiologists.

Can aspirin be stopped in primary prevention?
Recent trials show that starting aspirin for primary prevention in adults without prior cardiovascular disease offers minimal net benefit and raises bleeding risk; many physicians now advise against initiating it in this setting and may discontinue it if already in use.

How do doctors decide to stop aspirin before surgery?
For elective procedures with moderate-to-high bleeding risk, aspirin is typically held 5–7 days beforehand and restarted once hemostasis is secure; cardiologists weigh stent thrombosis risk against surgical bleeding risk in patients with recent stents.

What monitoring helps guide stopping or continuing aspirin?
No routine blood test measures aspirin effect in daily practice. Decisions rest on clinical history, bleeding episodes, concurrent medications, and periodic review of cardiovascular risk status.

When might long-term aspirin still be appropriate?
Patients with established coronary or cerebrovascular disease, prior stents, or atrial fibrillation who cannot take anticoagulants usually continue aspirin indefinitely unless bleeding forces a change.